DGAP-Adhoc: QIAGEN N.V.: QIAGEN announces deviation from preliminary sales result expectations for the third quarter of 2019

2019. október 07., hétfő, 22:04





DGAP-Ad-hoc: QIAGEN N.V. / Key word(s): Preliminary Results


QIAGEN N.V.: QIAGEN announces deviation from preliminary sales result expectations for the third quarter of 2019


07-Oct-2019 / 22:04 CET/CEST


Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.


The issuer is solely responsible for the content of this announcement.




English Version



Ad-hoc Announcement pursuant to Article 17 Market Abuse Regulation



QIAGEN announces deviation from preliminary sales result expectations for the third quarter of 2019



Venlo, The Netherlands, October 07, 2019 - QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announces preliminary sales results for the third quarter of 2019 fall short of expectations.



For the third quarter of 2019, QIAGEN currently expects preliminary total net sales growth of about 3% at constant exchange rates (CER) compared to the outlook for about 4-5% CER growth, and mainly due to significantly weaker-than-expected developments in China. Total sales growth was about 6% CER excluding China sales. QIAGEN anticipates adjusted EPS within its outlook for approximately $0.35-0.36 CER.



QIAGEN N.V.



Hulsterweg 82



5912 PL Venlo



The Netherlands



ISIN: NL0012169213



Frankfurt Stock Exchange, regulated market (Prime Standard)



Contacts



John Gilardi



Vice President, Head of Corporate Communications and Investor Relations



+49 2103 29 11711 and +1 240 686 2222



john.gilardi@qiagen.com











07-Oct-2019 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de





























Language: English
Company: QIAGEN N.V.

Hulsterweg 82

5912 PL Venlo

Netherlands
Phone: +31 7735566 - 00
Fax: +31 77 35566-58
E-mail: qiagen@qiagen.com
Internet: www.qiagen.com
ISIN: NL0012169213
WKN: A2DKCH
Indices: MDAX, TecDAX
Listed: Regulated Market in Berlin, Frankfurt (Prime Standard); Regulated Unofficial Market in Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange; London, Chicago, NYSE, SIX
EQS News ID: 886525





 
End of Announcement DGAP News Service




886525  07-Oct-2019 CET/CEST







fncls.ssp?fn=show_t_gif&application_id=886525&application_name=news&site_id=geo_holding_tug
Tilos a hír bármilyen adatbázisba történő mentése vagy annak továbbítása harmadik fél számára;kereskedelmi viszonylatban vagy kereskedelmi céllal csak a Deutsche Gesellschaft für Ad-hoc-Publizität mbh írásos engedélyével történhet.